Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07464236 · ClinicalTrials.gov registry record · NA
Improving Clinic Delivery of HIV-related Anal Health Services
A NA study, sponsored by Albert Einstein College of Medicine.
- Not yet
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT07464236: Clinical Trial NA study, sponsored by Albert Einstein College of Medicine.
NCT07464236 is a NA study that has not yet begun recruiting, run by Albert Einstein College of Medicine. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07464236, a NA study, has not yet begun recruiting, sponsored by Albert Einstein College of Medicine.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This project will test ways to reduce stigma in healthcare settings so that more providers offer, and more patients receive, important anal sex-related HIV services, including anorectal sexually transmitted infection (STI) testing, preventive medications, and cancer screening. By evaluating these stigma-reduction strategies in eight clinics in the Mississippi Delta, a region with high rates of HIV and STIs, the research team will learn whether and how these approaches work to improve access to care. The results will help guide healthcare systems in using the most effective methods to reduce stigma, making it easier for people to get prevention services and improving public health.
Primary Outcome
Clinics will extract deidentified patient level outcomes from the medical record system on a monthly basis. This data will be imported into an audit-and-feedback data dashboard developed by the PEACHES 2.0 team. For patient uptake of anorectal STI screening, the number of anorectal STI screening orders per month among all STI orders in that same month will be calculated, and the slopes across the three 12-month data collection periods: Pre-Implementation, Implementation, and Maintenance periods
Interventions
- BEHAVIORAL PEACHES 2.0 Implementation Strategies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2030-07-31 |
| Phase | NA |
What is known before NCT07464236 opens enrollment
NCT07464236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which PEACHES 2.0 Implementation Strategies is the first listed.
NCT07464236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07464236 about?
NCT07464236 is a clinical study titled "Improving Clinic Delivery of HIV-related Anal Health Services". This project will test ways to reduce stigma in healthcare settings so that more providers offer, and more patients receive, important anal sex-related HIV services, including anorectal sexually transmitted infection (STI) testing, preventive medications, and cancer screening. By evaluating these st...
What is the current status of trial NCT07464236?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2026-08-01. Estimated completion is 2030-07-31.
What interventions are being tested in trial NCT07464236?
The interventions under investigation include: PEACHES 2.0 Implementation Strategies (BEHAVIORAL).
Who is sponsoring clinical trial NCT07464236?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07464236's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI